Cavenee WK - Search Results

1

DNA hypermethylation is associated with 17p allelic loss in neural tumors.

Makos M, Nelkin BD, Chazin VR, Cavenee WK, Brodeur GM, Baylin SB. Makos M, et al. Among authors: cavenee wk. Cancer Res. 1993 Jun 15;53(12):2715-8. Cancer Res. 1993. PMID: 8389241

2

Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas.

Fong CT, White PS, Peterson K, Sapienza C, Cavenee WK, Kern SE, Vogelstein B, Cantor AB, Look AT, Brodeur GM. Fong CT, et al. Among authors: cavenee wk. Cancer Res. 1992 Apr 1;52(7):1780-5. Cancer Res. 1992. PMID: 1551108

3

Developmental genetics and childhood cancer. AACR special conference in cancer research.

Knudson A, Vande Woude GF, Friend SH, Cavenee WK, Brodeur GM. Knudson A, et al. Among authors: cavenee wk. Cancer Res. 1991 Oct 1;51(19):5435-9. Cancer Res. 1991. PMID: 1655251 No abstract available.

4

Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors.

James CD, He J, Carlbom E, Nordenskjold M, Cavenee WK, Collins VP. James CD, et al. Among authors: cavenee wk. Cancer Res. 1991 Mar 15;51(6):1684-8. Cancer Res. 1991. PMID: 1998958

5

Concordant deletions of chromosome 3p and loss of heterozygosity for chromosomes 13 and 17 in small cell lung carcinoma.

Mori N, Yokota J, Oshimura M, Cavenee WK, Mizoguchi H, Noguchi M, Shimosato Y, Sugimura T, Terada M. Mori N, et al. Among authors: cavenee wk. Cancer Res. 1989 Sep 15;49(18):5130-5. Cancer Res. 1989. PMID: 2569931

6

Clonal genomic alterations in glioma malignancy stages.

James CD, Carlbom E, Dumanski JP, Hansen M, Nordenskjold M, Collins VP, Cavenee WK. James CD, et al. Among authors: cavenee wk. Cancer Res. 1988 Oct 1;48(19):5546-51. Cancer Res. 1988. PMID: 2901288

7

Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells.

Van Meir EG, Polverini PJ, Chazin VR, Su Huang HJ, de Tribolet N, Cavenee WK. Van Meir EG, et al. Among authors: cavenee wk. Nat Genet. 1994 Oct;8(2):171-6. doi: 10.1038/ng1094-171. Nat Genet. 1994. PMID: 7531056

8

p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3.

Wales MM, Biel MA, el Deiry W, Nelkin BD, Issa JP, Cavenee WK, Kuerbitz SJ, Baylin SB. Wales MM, et al. Among authors: cavenee wk. Nat Med. 1995 Jun;1(6):570-7. doi: 10.1038/nm0695-570. Nat Med. 1995. PMID: 7585125

9

Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.

Negrini M, Rasio D, Hampton GM, Sabbioni S, Rattan S, Carter SL, Rosenberg AL, Schwartz GF, Shiloh Y, Cavenee WK, et al. Negrini M, et al. Among authors: cavenee wk. Cancer Res. 1995 Jul 15;55(14):3003-7. Cancer Res. 1995. PMID: 7606718

10

A defined region of loss of heterozygosity at 11q23 in cutaneous malignant melanoma.

Herbst RA, Larson A, Weiss J, Cavenee WK, Hampton GM, Arden KC. Herbst RA, et al. Among authors: cavenee wk. Cancer Res. 1995 Jun 15;55(12):2494-6. Cancer Res. 1995. PMID: 7780954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters